CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise | +789 | 8,800.75 | ||
| 2026-02-06 | Kramer Robin Chief Financial Officer | Shares withheld for taxes | −273 | $201.18 | $55K | 8,527.75 |
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise | +703 | 9,230.75 | ||
| 2026-02-06 | Kramer Robin Chief Financial Officer | Shares withheld for taxes | −207 | $201.18 | $42K | 9,023.75 |
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise | +3,511 | 12,534.75 | ||
| 2026-02-06 | Kramer Robin Chief Financial Officer | Shares withheld for taxes | −1,063 | $201.18 | $214K | 11,471.75 |
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise · Restricted Stock Unit | −789 | 0 | ||
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise · Restricted Stock Unit | −703 | 704 | ||
| 2026-02-06 | Kramer Robin Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,511 | 7,024 | ||
| 2026-02-06 | Keeney Adam Head of Corporate Development | Option exercise | +1,802 | 4,186 | ||
| 2026-02-06 | Keeney Adam Head of Corporate Development | Shares withheld for taxes | −589 | $201.18 | $118K | 3,597 |
| 2026-02-06 | Keeney Adam Head of Corporate Development | Option exercise | +3,278 | 6,875 | ||
| 2026-02-06 | Keeney Adam Head of Corporate Development | Shares withheld for taxes | −994 | $201.18 | $200K | 5,881 |
| 2026-02-06 | Keeney Adam Head of Corporate Development | Option exercise · Restricted Stock Unit | −1,802 | 1,802 | ||
| 2026-02-06 | Keeney Adam Head of Corporate Development | Option exercise · Restricted Stock Unit | −3,278 | 6,557 | ||
| 2026-02-06 | Izzar Rachid Head of Global Product Strat. | Option exercise | +2,044 | 8,204 | ||
| 2026-02-06 | Izzar Rachid Head of Global Product Strat. | Shares withheld for taxes | −805 | $201.18 | $162K | 7,399 |
| 2026-02-06 | Izzar Rachid Head of Global Product Strat. | Option exercise | +1,802 | 9,201 | ||
| 2026-02-06 | Izzar Rachid Head of Global Product Strat. | Shares withheld for taxes | −458 | $201.18 | $92K | 8,743 |
| 2026-02-06 | Izzar Rachid Head of Global Product Strat. | Option exercise | +3,043 | 11,786 |
Page 4 of 29 · 579 trades